Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

Cannabinoids for treating neurogenic lower urinary tract dys — 2017 Meta-analysis - | BudProfiles

Home

Studies

Cannabinoids for treating neurogenic lower urinary...

PositiveMeta-analysis -2017

Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis.

View Study

Classification Results

AI Classification

Positive

Fine-tuned Classification

Positive

Conditions Studied

Multiple Sclerosis

Related Studies

Positive

Unraveling endocannabinoid signaling disruption in a preclinical model of neurodevelopmental disorders

2025·Review/Other

N/A

Cannabinoids and the endocannabinoid system in the regulation of cytochrome P450 metabolic activity-a review

2025·Review/Other

N/A

The use of cannabidiol (CBD) to improve sleep: a systematic review

2025·Meta-analysis -

Inconclusive

Specific features of cannabidiol metabolism and excretion during long-term consumption of cannabis

2025·Review/Other

Inconclusive

Recreational drugs repurposed for medicinal use—cannabis

2025·Review/Other

Inconclusive

Region-Specific Impact of Repeated Synthetic Cannabinoid Exposure and Withdrawal on Endocannabinoid Signaling, Gliosis, and Inflammatory Markers in the Prefrontal Cortex and Hippocampus

2025·Review/Other

Organ Systems

Nervous SystemUrinary System

Study Details

Type: Meta-analysis -
Year: 2017
Study ID: #2017255